» Articles » PMID: 36194925

Differential Associations Between Pre-diabetes, Diabetes and Stroke Occurrence Among West Africans

Abstract

Background: There are limited data from Africa on the burden and associations between pre-diabetes (pre-DM), diabetes mellitus (DM) and stroke occurrence in a region experiencing a profound rise in stroke burden.

Purpose: To characterize the associations between stroke and dysglycemic status among West Africans.

Methods: The Stroke Investigative Research and Educational Network (SIREN) is a multicenter, case-control study involving 15 sites in Ghana and Nigeria. Cases include adults aged ≥18 years with clinical and radiological evidence of an acute stroke. Controls were age-and-gender matched stroke-free adults. Detailed evaluations for vascular factors were performed. Pre-diabetes was defined as HBA1c of 5.7%-6.4% or Fasting blood glucose (FBG) 5.6-7.0 mmol/L and DM as HBA1c >6.5% or FBG>7.0 mmol/L. We used conditional logistic regression to estimate adjusted odds ratios (aOR) with 95% Confidence Interval.

Results: Among 2,935 stroke cases the mean age was 60.0 ± 14.2 years with 55.2% being males. By glycemic status, 931 (31.7%) were euglycemic, 633 (21.6%) had Pre-diabetes and 1371 (46.7%) had DM. Of the age- and sex-matched stroke-free controls 69.2% were euglycemic, 13.3% had pre-DM and 17.5% had DM. Pre-DM [aOR (95% CI): 3.68(2.61-5.21)] and DM [4.29 (3.19-5.74)] were independently associated with stroke. The aOR of Pre-DM for ischemic stroke 3.06 (2.01-4.64)] was lower than 4.82 (3.37-6.89) for DM. However, the aOR of Pre-DM for hemorrhagic stroke 6.81 (95% CI: 3.29 - 14.08)] was higher than 3.36 (1.94-5.86) for DM. Furthermore, the aOR of pre-DM for ischemic stroke subtypes were 9.64 (1.30-71.57) for cardio-embolic stroke, 3.64 (1.80-7.34) for small-vessel occlusive disease and 4.63 (0.80-26.65) for large-vessel disease.

Conclusion: Pre-DM is strongly and independently associated with stroke in Africans. Improving glycemic control through screening, healthy lifestyle and pharmacotherapy at a population level may be strategic in reducing the rising burden of stroke in Africa.

References
1.
Sarfo F, Ovbiagele B, Gebregziabher M, Akpa O, Akpalu A, Wahab K . Unraveling the risk factors for spontaneous intracerebral hemorrhage among West Africans. Neurology. 2020; 94(10):e998-e1012. PMC: 7238923. DOI: 10.1212/WNL.0000000000009056. View

2.
Sarfo F, Ovbiagele B, Gebregziabher M, Wahab K, Akinyemi R, Akpalu A . Stroke Among Young West Africans: Evidence From the SIREN (Stroke Investigative Research and Educational Network) Large Multisite Case-Control Study. Stroke. 2018; 49(5):1116-1122. PMC: 5916042. DOI: 10.1161/STROKEAHA.118.020783. View

3.
Coccheri S . Approaches to prevention of cardiovascular complications and events in diabetes mellitus. Drugs. 2007; 67(7):997-1026. DOI: 10.2165/00003495-200767070-00005. View

4.
Feigin V . Stroke epidemiology in the developing world. Lancet. 2005; 365(9478):2160-1. DOI: 10.1016/S0140-6736(05)66755-4. View

5.
Ezejimofor M, Uthman O, Maduka O, Ezeabasili A, Onwuchekwa A, Ezejimofor B . Stroke survivors in Nigeria: A door-to-door prevalence survey from the Niger Delta region. J Neurol Sci. 2016; 372:262-269. DOI: 10.1016/j.jns.2016.11.059. View